3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Keratosis, Actinic
9
Uterine Cervical Dysplasia
3
Melanoma
3
Breast Neoplasms
3
Squamous Intraepithelial Lesions
2
Papillomavirus Infections
2
HIV Infections
2
Condylomata Acuminata
2
Vulvar Neoplasms
1
Vulvar High Grade Squamous Intraepithelial Lesion (HSIL)
1
Virus Diseases
1
Squamous Cell Carcinoma of Head and Neck
1
Sexually Transmitted Diseases
1
Pigmentation Disorders
1
Neoplasms
1
Keratosis
1
Hemangioma, Capillary
1
Glioblastoma
1
Breast Neoplasms, Male
1
Anus Neoplasms
1
Acquired Immunodeficiency Syndrome
1
Interventions
Valganciclovir
2
Rituximab
2
tocilizumab
1
human papillomavirus vaccine, L1 type 16, 18
1
Zidovudine
1
Watchful Waiting
1
Vincristine
1
Tobacco Use Cessation Devices
1
Surveys and Questionnaires
1
Sugars
1
Rapid Diagnostic Tests
1
Prednisone
1
Observation
1
Methotrexate
1
Maltose
1
Light Coagulation
1
Leucovorin
1
Laser Therapy
1
Interviews as Topic
1
Interferon-alpha
1
Imiquimod
1
Fluorouracil
1
Filgrastim
1
Etoposide
1
Enzyme-Linked Immunosorbent Assay
1
Electrocoagulation
1
Doxorubicin
1
Cyclophosphamide
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Acquired Immunodeficiency Syndrome
×
Imiquimod
×
Clear all
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts